hg_103232.1

Basic information about the TSS

---

TSS ID: hg_103232.1 Species: human Chr: chr9		Start: 136866277 End: 136866288 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000371649.5 BC015500 Distance: 0 GeneID: 8721 HGNC/MGI_ID: HGNC:3164 UniProt_ID: O60869

Gene_name: endothelial differentiation related factor 1 Gene_symbol: EDF1 Gene_synonyms: CFAP280 EDF-1 Gene_source: HGNC:3164

TATA-Box annotation

---

Distance to TSS:	25
Nearest PromoterID:	NM_001281298
Entrez ID:	8721
Nearest Unigene:	Hs.174050
Nearest Refseq:	NM_003792
Nearest Ensembl:	ENSG00000107223
Gene Name:	endothelial differentiation related factor 1
Gene Alias:	CFAP280|EDF-1|MBF1
Gene Description:	endothelial differentiation related factor 1
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EDF1 p2@EDF1 p3@EDF1
Sample		p1@EDF1	p2@EDF1	p3@EDF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	350.26	17.53	17.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	347.38	23.67	16.99
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	333.92	18.90	16.20
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	347.21	19.34	15.59
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	385.59	20.02	20.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	324.24	20.93	14.15
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	425.96	34.64	24.62
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	395.30	23.74	15.26
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	406.49	20.09	19.45
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	528.04	24.34	15.07
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	469.72	25.47	14.55
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	452.09	22.36	14.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	323.51	39.65	25.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	248.83	30.67	20.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	306.72	34.47	22.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	270.35	37.72	21.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	284.80	31.89	21.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	253.93	34.59	15.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	312.96	31.99	22.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	323.75	41.52	27.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	290.02	35.28	19.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	299.16	34.70	22.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	262.52	30.12	21.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	284.16	34.70	30.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	307.52	38.70	25.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	324.42	40.51	28.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	322.53	37.91	25.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	324.63	47.86	28.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	268.13	33.76	24.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	307.10	44.52	29.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	318.62	41.66	23.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	341.14	37.12	30.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	284.68	29.33	25.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	326.75	40.58	27.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	311.15	42.63	27.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	292.99	39.28	27.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	313.11	44.15	32.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	288.33	35.46	25.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	371.66	51.86	35.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	346.65	45.37	26.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	292.19	34.35	29.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	307.28	41.72	25.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	321.19	36.48	24.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	286.89	36.54	25.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	337.90	44.57	27.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	336.41	40.02	33.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	306.84	46.54	30.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	358.55	51.26	37.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	350.20	43.33	25.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	347.98	48.53	31.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	573.05	66.81	45.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	629.32	79.61	58.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	517.71	97.95	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	404.18	54.65	36.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	429.14	62.63	45.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	389.27	53.69	43.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	560.73	78.53	64.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	430.42	72.92	48.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	419.77	73.87	49.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	768.54	114.10	99.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	396.95	73.33	50.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	369.56	69.54	45.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	724.49	111.46	107.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	675.12	100.23	84.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	502.00	102.03	75.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	438.40	76.68	63.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	64.66	80.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	616.00	71.08	86.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	343.21	39.00	35.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	438.35	58.02	48.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	406.25	53.48	38.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	654.76	57.96	54.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	327.59	31.86	20.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	325.31	42.80	22.01
Adipocyte - breast, donor1	11376-118A8	267.19	27.40	22.17
Adipocyte - breast, donor2	11327-117E4	274.17	31.28	23.10
Adipocyte - omental, donor1	11473-119C6	226.59	22.65	19.34
Adipocyte - omental, donor2	11474-119C7	369.26	47.84	32.89
Adipocyte - omental, donor3	11475-119C8	339.27	41.53	41.53
Adipocyte - perirenal, donor1	11476-119C9	395.55	52.32	52.95
Adipocyte - subcutaneous, donor1	11259-116F8	288.07	15.39	30.79
Adipocyte - subcutaneous, donor2	11336-117F4	307.56	19.87	22.58
Adipocyte - subcutaneous, donor3	11408-118E4	320.79	20.51	16.33
Adipocyte differentiation, day04, donor1	13019-139D4	206.52	16.43	14.86
Adipocyte differentiation, day04, donor2	13022-139D7	279.51	19.82	18.27
Adipocyte differentiation, day04, donor3	13025-139E1	245.60	23.42	22.86
Adipocyte differentiation, day04, donor4	13028-139E4	355.04	24.69	25.28
Adipocyte differentiation, day08, donor1	13020-139D5	212.67	20.19	15.60
Adipocyte differentiation, day08, donor2	13023-139D8	306.29	26.47	21.30
Adipocyte differentiation, day08, donor3	13026-139E2	267.13	17.60	21.33
Adipocyte differentiation, day08, donor4	13029-139E5	278.77	19.48	21.70
Adipocyte differentiation, day12, donor1	13021-139D6	333.13	31.61	37.43
Adipocyte differentiation, day12, donor2	13024-139D9	239.86	29.14	25.87
Adipocyte differentiation, day12, donor3	13027-139E3	267.36	21.27	22.58
Adipocyte differentiation, day12, donor4	13030-139E6	228.96	15.22	16.44
Alveolar Epithelial Cells, donor1	11510-119G7	478.46	47.96	50.83
Alveolar Epithelial Cells, donor2	11590-120G6	1090.45	134.83	138.05
Alveolar Epithelial Cells, donor3	11671-122G6	414.51	43.13	26.36
Amniotic Epithelial Cells, donor1	11533-120A3	312.32	26.45	25.91
Amniotic Epithelial Cells, donor2	11613-122A2	530.50	45.18	31.80
Amniotic Epithelial Cells, donor3	11694-123A2	396.72	30.41	26.09
Anulus Pulposus Cell, donor1	11248-116E6	339.84	29.29	20.25
Anulus Pulposus Cell, donor2	11463-119B5	385.24	26.45	32.57
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	326.64	51.67	35.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	365.11	48.62	39.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	410.93	42.80	38.52
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	311.48	53.81	35.57
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	374.34	56.91	51.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	460.73	53.47	44.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	303.77	50.68	41.59
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	321.85	48.54	29.61
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	379.49	38.60	30.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	291.89	51.60	47.46
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	312.04	55.88	44.99
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	359.83	40.12	35.11
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	252.71	30.31	21.91
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	326.19	38.21	47.77
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	321.94	31.82	24.58
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	293.08	47.15	33.22
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	313.26	39.68	38.73
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	422.31	49.18	35.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	258.49	40.97	30.24
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	308.00	49.26	36.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	457.48	43.23	32.42
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	290.29	67.26	31.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	332.77	42.54	36.36
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	604.07	20.97	54.53
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	339.80	43.69	51.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	385.52	44.78	44.02
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	409.44	46.03	44.82
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	348.29	48.45	39.33
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	341.83	45.53	33.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	418.62	55.23	41.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	350.03	48.33	45.04
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	335.38	42.12	32.80
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	449.47	42.09	36.39
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	338.69	45.63	45.04
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	397.11	41.85	44.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	540.54	59.40	57.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	352.94	53.91	50.86
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	410.30	45.08	42.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	400.92	51.46	33.67
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	336.16	44.88	51.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	348.44	40.01	39.37
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	435.84	45.82	38.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	314.60	43.46	51.96
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	332.27	39.16	34.24
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	440.11	30.11	34.75
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	363.36	61.26	35.91
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	343.49	43.31	35.16
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	553.53	54.75	44.52
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	311.27	40.09	43.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	393.79	47.36	50.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	405.50	38.25	45.91
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	343.47	37.63	28.22
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	376.34	45.42	35.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	431.15	49.88	45.29
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	331.26	49.71	38.24
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	355.23	43.24	38.58
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	469.95	48.83	53.40
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	320.15	46.53	45.42
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	338.94	44.75	38.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	454.67	52.34	46.88
Astrocyte - cerebellum, donor1	11500-119F6	499.86	36.84	35.99
Astrocyte - cerebellum, donor2	11580-120F5	587.59	62.30	56.31
Astrocyte - cerebellum, donor3	11661-122F5	479.48	39.85	33.35
Astrocyte - cerebral cortex, donor1	11235-116D2	297.34	38.69	22.66
Astrocyte - cerebral cortex, donor2	11316-117D2	327.92	43.84	29.28
Astrocyte - cerebral cortex, donor3	11392-118C6	303.39	36.69	29.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	361.03	49.31	29.70
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	352.29	60.51	39.59
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	356.41	55.76	36.19
Basophils, donor1	12241-129G9	281.67	27.46	30.60
Basophils, donor2	12242-129H1	291.52	29.59	25.98
Basophils, donor3	12243-129H2	154.35	16.90	13.38
Bronchial Epithelial Cell, donor1	11511-119G8	353.59	23.93	21.34
Bronchial Epithelial Cell, donor2	11591-120G7	605.31	42.06	27.43
Bronchial Epithelial Cell, donor3	11672-122G7	408.89	21.52	28.69
Bronchial Epithelial Cell, donor4	11453-119A4	296.88	30.75	28.87
Bronchial Epithelial Cell, donor5	11457-119A8	259.52	32.23	17.05
Bronchial Epithelial Cell, donor6	11461-119B3	255.85	15.66	15.43
Bronchial Epithelial Cell, donor7	11769-123I5	256.96	13.86	14.76
Burkitt's lymphoma cell line:DAUDI	10422-106C8	214.05	48.02	27.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	400.83	40.76	30.28
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	391.72	50.52	28.46
CD133+ stem cells - cord blood derived, pool1	12223-129E9	351.63	72.39	20.68
CD14+ Monocytes, donor1	11224-116B9	219.79	24.80	20.29
CD14+ Monocytes, donor2	11305-117B9	261.88	28.21	20.60
CD14+ Monocytes, donor3	11381-118B4	238.42	30.52	21.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	205.77	29.72	30.29
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	206.22	30.71	25.40
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	200.53	21.04	22.03
CD14+ monocytes - mock treated, donor1	11863-125A9	244.00	33.97	19.37
CD14+ monocytes - mock treated, donor2	11873-125C1	209.71	18.71	19.31
CD14+ monocytes - mock treated, donor3	11883-125D2	217.23	27.72	21.32
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	231.18	23.60	19.92
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	211.42	18.49	14.63
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	222.64	23.55	28.02
CD14+ monocytes - treated with BCG, donor1	11860-125A6	227.91	22.52	15.86
CD14+ monocytes - treated with BCG, donor2	11870-125B7	217.04	19.05	13.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	262.03	18.28	23.29
CD14+ monocytes - treated with Candida, donor1	11868-125B5	213.99	16.62	12.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	265.07	15.31	19.54
CD14+ monocytes - treated with Candida, donor3	11888-125D7	214.11	16.64	15.53
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	211.22	26.33	16.66
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	211.92	27.74	21.75
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	246.30	28.11	29.15
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	238.85	22.88	17.16
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	230.28	14.70	15.38
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	174.15	15.71	16.59
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	251.77	27.44	21.52
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	252.79	25.82	17.45
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	278.16	24.41	26.93
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	207.96	20.21	14.33
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	251.17	17.26	15.85
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	207.08	14.92	13.16
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	198.09	17.61	15.34
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	225.24	14.87	13.38
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	264.26	19.18	21.77
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	246.10	22.11	15.56
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	221.60	12.29	12.05
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	195.80	16.47	17.86
CD14+CD16+ Monocytes, donor1	11789-124B7	306.68	24.19	27.46
CD14+CD16+ Monocytes, donor2	11801-124D1	297.75	21.02	26.80
CD14+CD16+ Monocytes, donor3	11912-125G4	307.16	29.68	36.17
CD14+CD16- Monocytes, donor1	11788-124B6	317.05	34.57	31.30
CD14+CD16- Monocytes, donor2	11799-124C8	289.91	27.42	27.42
CD14+CD16- Monocytes, donor3	11910-125G2	315.50	27.65	24.75
CD14-CD16+ Monocytes, donor1	11790-124B8	330.71	28.07	29.35
CD14-CD16+ Monocytes, donor2	11800-124C9	268.75	24.37	16.03
CD14-CD16+ Monocytes, donor3	11911-125G3	357.93	21.27	27.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	520.27	50.81	48.78
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	467.13	63.73	51.53
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	503.30	42.46	50.74
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	456.28	42.64	40.51
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	576.27	61.11	48.78
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	434.50	44.92	48.43
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	511.40	45.49	48.63
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	519.40	69.87	47.46
CD19+ B Cells, donor1	11544-120B5	448.76	23.84	32.88
CD19+ B Cells, donor2	11624-122B4	415.67	28.29	21.04
CD19+ B Cells, donor3	11705-123B4	363.98	24.23	24.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	447.29	28.69	31.11
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	399.09	29.16	31.96
CD34+ Progenitors, donor1	11545-120B6	242.98	34.14	19.08
CD34+ Progenitors, donor2	11625-122B5	305.06	29.78	26.40
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	291.96	35.32	26.68
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	343.19	46.00	36.98
CD4+ T Cells, donor1	11225-116C1	362.41	28.92	22.49
CD4+ T Cells, donor2	11306-117C1	522.96	41.03	31.84
CD4+ T Cells, donor3	11382-118B5	451.39	49.41	38.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	344.06	46.71	41.60
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	462.67	39.30	38.41
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	505.36	48.58	45.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	595.93	48.83	35.08
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	649.65	52.67	42.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	787.80	46.15	52.74
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	324.15	58.67	42.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	519.06	81.00	69.82
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	497.16	80.93	70.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	433.95	46.62	40.80
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	453.51	50.31	46.47
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	507.74	40.48	45.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	448.63	56.50	52.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	583.42	105.96	76.46
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	639.85	106.25	94.89
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	540.06	35.90	32.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	563.28	38.59	30.55
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	735.22	60.97	43.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	416.10	60.64	49.51
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	299.58	47.22	35.53
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	342.76	49.81	40.14
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	483.36	41.97	51.07
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	514.70	56.32	49.82
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	450.63	43.58	40.09
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	659.66	69.28	58.89
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	683.16	64.62	76.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	679.77	69.79	75.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	672.94	55.11	51.79
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	689.06	62.08	55.95
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	794.64	61.60	58.52
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	643.90	58.37	51.21
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	728.51	91.41	85.87
CD8+ T Cells, donor1	11226-116C2	336.56	30.45	24.23
CD8+ T Cells, donor2	11307-117C2	360.04	45.43	36.04
CD8+ T Cells, donor3	11383-118B6	377.22	40.65	29.29
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	376.43	33.49	36.70
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	338.61	31.15	34.99
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	332.69	32.01	35.29
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	291.51	30.32	30.32
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	321.58	29.04	29.52
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	352.45	30.24	32.97
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	350.26	35.63	35.42
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	367.17	33.43	32.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	331.84	35.41	39.87
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	335.08	34.72	31.70
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	330.88	33.12	37.48
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	366.08	34.90	31.17
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	229.38	32.83	16.20
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	255.95	24.14	17.76
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	272.99	26.85	18.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	404.81	37.82	35.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	326.56	26.76	31.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	338.46	28.99	24.98
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	311.83	29.16	32.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	367.85	32.91	33.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	337.89	28.53	36.55
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	332.75	31.36	29.83
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	317.25	30.74	31.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	335.85	28.74	27.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	230.45	13.65	24.89
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	229.41	13.99	15.39
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	224.39	10.02	23.04
Cardiac Myocyte, donor1	11525-119I4	345.44	62.14	47.52
Cardiac Myocyte, donor2	11605-120I3	310.78	29.15	29.65
Cardiac Myocyte, donor3	11686-122I3	208.99	22.31	15.57
Chondrocyte - de diff, donor1	11261-116G1	597.31	48.88	40.21
Chondrocyte - de diff, donor2	11338-117F6	272.57	36.60	25.59
Chondrocyte - de diff, donor3	11410-118E6	316.65	40.28	28.33
Chondrocyte - re diff, donor2	11339-117F7	290.96	32.23	32.23
Chondrocyte - re diff, donor3	11411-118E7	298.45	33.97	27.10
Ciliary Epithelial Cells, donor1	11242-116D9	261.76	30.64	21.69
Ciliary Epithelial Cells, donor2	11323-117D9	286.66	32.92	30.14
Ciliary Epithelial Cells, donor3	11399-118D4	268.24	30.97	20.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	285.83	41.17	33.20
Corneal Epithelial Cells, donor1	11526-119I5	351.54	19.10	16.25
Corneal Epithelial Cells, donor2	11606-120I4	500.54	37.54	43.23
Corneal Epithelial Cells, donor3	11687-122I4	380.89	40.65	24.03
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	173.02	47.71	34.67
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	147.61	43.84	37.22
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	193.24	51.76	37.96
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	180.88	47.73	38.23
Dendritic Cells - plasmacytoid, donor1	11228-116C4	315.34	35.87	32.46
Dendritic Cells - plasmacytoid, donor2	11309-117C4	458.31	68.55	39.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	399.74	43.07	44.52
Endothelial Cells - Aortic, donor0	11207-116A1	204.29	48.03	26.02
Endothelial Cells - Aortic, donor1	11263-116G3	248.79	38.73	24.06
Endothelial Cells - Aortic, donor2	11340-117F8	363.39	35.35	35.07
Endothelial Cells - Aortic, donor3	11412-118E8	327.13	41.28	14.55
Endothelial Cells - Artery, donor1	11264-116G4	305.71	39.27	32.87
Endothelial Cells - Artery, donor2	11341-117F9	320.68	59.76	40.00
Endothelial Cells - Artery, donor3	11413-118E9	179.69	39.97	22.09
Endothelial Cells - Lymphatic, donor1	11236-116D3	186.85	34.13	19.28
Endothelial Cells - Lymphatic, donor2	11317-117D3	200.21	22.52	17.34
Endothelial Cells - Lymphatic, donor3	11393-118C7	179.57	20.30	17.48
Endothelial Cells - Microvascular, donor1	11265-116G5	432.92	50.81	33.58
Endothelial Cells - Microvascular, donor2	11342-117G1	251.48	33.32	27.07
Endothelial Cells - Microvascular, donor3	11414-118F1	291.66	40.41	28.64
Endothelial Cells - Thoracic, donor1	11266-116G6	363.31	46.41	34.41
Endothelial Cells - Thoracic, donor2	11343-117G2	421.40	49.27	46.12
Endothelial Cells - Umbilical vein, donor1	11243-116E1	253.96	41.13	19.51
Endothelial Cells - Umbilical vein, donor2	11324-117E1	368.91	46.49	34.76
Endothelial Cells - Umbilical vein, donor3	11400-118D5	311.43	42.74	30.17
Endothelial Cells - Vein, donor1	11267-116G7	238.88	39.81	22.75
Endothelial Cells - Vein, donor2	11344-117G3	199.07	32.13	26.54
Endothelial Cells - Vein, donor3	11416-118F3	290.93	52.91	33.76
Eosinophils, donor1	12244-129H3	335.43	45.74	45.74
Eosinophils, donor2	12245-129H4	204.63	31.35	19.80
Eosinophils, donor3	12246-129H5	167.64	24.97	14.27
Esophageal Epithelial Cells, donor1	11507-119G4	282.20	21.01	15.64
Esophageal Epithelial Cells, donor2	11587-120G3	461.80	33.28	45.76
Esophageal Epithelial Cells, donor3	11668-122G3	569.41	16.27	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	436.79	74.30	49.26
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	231.13	39.53	28.25
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	402.26	37.27	34.23
Fibroblast - Aortic Adventitial, donor1	11245-116E3	260.02	36.75	25.59
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	246.19	39.30	30.16
Fibroblast - Aortic Adventitial, donor2	11326-117E3	365.56	40.92	29.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	212.11	24.77	25.03
Fibroblast - Aortic Adventitial, donor3	11401-118D6	272.07	30.23	22.92
Fibroblast - Cardiac, donor1	11268-116G8	294.40	35.84	31.75
Fibroblast - Cardiac, donor2	11345-117G4	292.57	26.53	26.53
Fibroblast - Cardiac, donor3	11417-118F4	274.58	49.21	32.02
Fibroblast - Cardiac, donor4	11452-119A3	137.00	16.06	9.70
Fibroblast - Cardiac, donor5	11456-119A7	301.02	36.29	25.51
Fibroblast - Cardiac, donor6	11460-119B2	289.85	37.14	23.95
Fibroblast - Choroid Plexus, donor1	11492-119E7	351.06	25.59	31.89
Fibroblast - Choroid Plexus, donor2	11572-120E6	340.40	27.18	28.04
Fibroblast - Choroid Plexus, donor3	11653-122E6	288.56	17.58	13.18
Fibroblast - Conjunctival, donor1	11531-120A1	502.79	19.37	24.91
Fibroblast - Conjunctival, donor3	11692-122I9	226.59	13.91	11.02
Fibroblast - Dermal, donor1	11269-116G9	270.70	22.30	13.62
Fibroblast - Dermal, donor2	11346-117G5	245.74	31.13	20.28
Fibroblast - Dermal, donor3	11418-118F5	270.06	26.23	14.63
Fibroblast - Dermal, donor4	11450-119A1	305.22	25.55	19.56
Fibroblast - Dermal, donor5	11454-119A5	318.03	31.23	28.78
Fibroblast - Dermal, donor6	11458-119A9	330.37	33.95	22.90
Fibroblast - Gingival, donor1	11237-116D4	211.14	18.53	13.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	296.06	42.44	26.99
Fibroblast - Gingival, donor2	11318-117D4	353.58	30.97	24.91
Fibroblast - Gingival, donor3	11394-118C8	241.62	15.95	12.76
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	345.95	44.67	19.74
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	362.63	38.41	30.13
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	327.23	38.97	27.28
Fibroblast - Gingival, donor6 (control)	11922-125H5	304.40	37.05	25.83
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	79.75	10.94	7.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	399.98	40.80	31.74
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	359.43	41.18	28.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	354.42	37.84	25.01
Fibroblast - Gingival, donor9 (control)	11927-125I1	358.19	28.76	22.16
Fibroblast - Lung, donor1	11270-116H1	165.84	13.59	6.80
Fibroblast - Lung, donor2	11347-117G6	232.78	5.97	16.41
Fibroblast - Lung, donor3	11419-118F6	292.07	32.71	23.21
Fibroblast - Lymphatic, donor1	11506-119G3	507.31	22.49	24.16
Fibroblast - Lymphatic, donor2	11586-120G2	398.61	23.78	34.97
Fibroblast - Lymphatic, donor3	11667-122G2	431.57	30.79	27.15
Fibroblast - Mammary, donor1	11540-120B1	267.13	21.52	19.49
Fibroblast - Mammary, donor2	11620-122A9	778.87	51.92	31.95
Fibroblast - Mammary, donor3	11701-123A9	357.38	29.78	59.56
Fibroblast - Periodontal Ligament, donor1	11238-116D5	275.05	25.80	15.71
Fibroblast - Periodontal Ligament, donor2	11319-117D5	329.60	27.30	20.63
Fibroblast - Periodontal Ligament, donor3	11395-118C9	140.14	10.71	12.24
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	380.86	32.82	24.42
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	413.35	45.63	36.45
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	339.80	37.23	25.75
Fibroblast - Pulmonary Artery, donor1	11250-116E8	267.49	39.24	25.20
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	322.87	21.54	19.10
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	497.81	46.11	34.75
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	309.57	32.42	22.93
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	237.54	25.40	20.64
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	284.37	23.09	20.43
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	312.58	17.93	21.48
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	300.55	34.00	37.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	335.73	30.98	26.77
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	346.21	51.63	42.01
Fibroblast - skin normal, donor1	11553-120C5	327.34	32.65	29.70
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	274.29	34.49	25.87
Fibroblast - skin normal, donor2	11561-120D4	382.16	35.46	29.84
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	391.10	48.96	42.01
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	347.12	26.43	18.64
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	422.08	19.32	24.96
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	254.21	34.81	32.51
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	349.50	37.39	32.60
Fibroblast - skin walker warburg, donor1	11554-120C6	299.41	32.56	23.62
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	343.75	50.34	48.77
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	487.52	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	583.05	84.54	58.39
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	231.43	32.59	27.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	214.70	23.16	13.79
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	218.72	26.83	18.65
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	771.68	166.12	77.32
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	651.47	144.84	74.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	897.73	140.06	89.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	866.43	56.25	43.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	674.25	58.91	48.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	755.47	110.75	67.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	826.05	55.25	41.50
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	813.08	84.15	62.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	902.58	130.90	87.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	278.83	57.52	36.32
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	278.55	53.32	28.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	324.77	57.22	33.85
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	307.26	39.77	22.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	339.56	42.50	31.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	370.21	51.64	27.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	368.74	36.05	32.86
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	277.66	39.11	27.90
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	328.74	44.81	21.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	372.30	42.84	22.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	272.61	38.79	30.68
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	291.79	30.61	22.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	342.78	33.27	20.77
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	274.65	43.94	33.25
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	285.26	32.90	18.36
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	291.04	20.08	13.01
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	321.57	17.25	15.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	261.81	33.31	27.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	272.05	29.04	20.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	325.46	29.40	25.93
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	347.42	26.61	19.39
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	250.99	25.48	22.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	296.84	36.35	24.85
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	339.68	24.91	24.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	290.14	27.43	20.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	313.65	35.34	25.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	430.40	25.66	15.72
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	238.59	33.92	26.06
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	293.42	31.32	20.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	402.31	34.06	29.19
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	230.51	37.84	28.85
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	287.40	24.15	20.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	337.50	30.58	22.72
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	194.43	32.87	28.05
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	332.65	31.82	31.82
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	297.60	39.63	27.54
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	251.69	39.51	34.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	284.36	26.02	18.70
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	316.72	30.23	25.62
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	319.98	34.65	23.25
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	226.12	12.89	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	289.55	28.89	21.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	298.00	26.63	22.80
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.80	11.44	8.64
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	370.05	56.33	34.84
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	268.55	52.69	31.43
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	342.06	71.19	43.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	442.80	82.61	48.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	434.29	76.01	43.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	452.44	77.48	50.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	492.48	61.87	42.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	586.79	91.29	82.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	919.36	70.60	91.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	467.74	62.60	60.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	546.80	70.63	58.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	496.22	57.65	60.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	413.20	26.66	23.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	545.31	63.76	59.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	523.28	55.24	64.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	355.67	38.59	29.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	603.70	58.84	55.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	529.19	59.10	56.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	490.71	66.82	37.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	712.44	53.26	40.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	550.82	38.77	41.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	479.44	71.15	40.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	556.70	84.50	65.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	518.94	69.04	74.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	632.22	126.44	31.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	523.57	51.51	49.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	515.36	54.76	58.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	599.95	49.49	50.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	535.52	30.05	29.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	508.03	39.03	34.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	484.53	19.88	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	735.14	36.80	37.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	566.68	25.95	26.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	574.29	32.56	19.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	613.41	40.68	47.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	622.61	37.99	39.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	631.54	35.41	23.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	677.96	32.09	33.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	536.75	22.82	21.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	483.19	28.82	16.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	460.82	45.96	46.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	518.73	59.69	58.71
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	245.38	35.38	27.39
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	326.00	44.49	30.77
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	308.10	41.60	39.36
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	354.27	19.98	14.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	361.76	26.32	27.15
Hep-2 cells mock treated, biol_rep1	11898-125E8	402.43	80.30	59.76
Hep-2 cells mock treated, biol_rep2	11899-125E9	387.06	58.07	58.41
Hep-2 cells mock treated, biol_rep3	11900-125F1	333.29	59.83	50.96
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	398.98	75.64	61.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	408.12	63.61	55.88
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	345.96	56.19	55.33
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	410.35	73.10	63.27
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	365.74	60.21	54.38
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	336.39	54.78	47.42
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	397.33	45.33	48.13
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	446.21	43.28	36.35
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	539.34	37.01	42.30
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	376.00	27.87	29.63
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	533.99	34.87	36.33
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	297.05	33.74	31.30
Hepatocyte, donor1	11523-119I2	660.99	77.48	101.69
Hepatocyte, donor2	11603-120I1	541.90	80.80	81.88
Hepatocyte, donor3	11684-122I1	380.39	47.86	63.81
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	392.26	44.38	45.04
Intestinal epithelial cells (polarized), donor1	11246-116E4	253.43	49.99	36.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	206.50	24.29	18.93
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	187.85	15.92	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	541.67	27.08	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	228.42	18.00	20.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	320.34	22.52	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	581.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	207.60	17.94	15.38
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	315.38	13.71	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	261.52	19.49	12.99
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	296.78	25.01	13.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	330.38	21.78	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	202.49	25.15	25.15
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	272.73	15.52	18.85
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	314.30	26.19	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	210.37	15.75	13.86
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	250.55	23.20	20.11
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	380.50	58.54	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	188.00	22.61	14.21
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	209.29	19.32	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	382.34	35.84	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	211.05	19.56	21.19
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	157.01	20.57	9.24
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	330.57	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	192.08	23.31	15.27
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	260.37	17.54	17.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	226.21	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	234.13	21.71	13.69
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	225.84	21.77	16.33
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	368.56	29.48	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	199.08	24.75	22.60
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	316.35	21.60	13.98
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	558.63	32.86	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	192.58	23.59	15.94
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	257.00	29.16	23.69
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	316.09	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	167.81	17.85	12.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	192.46	16.59	13.27
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	375.27	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	238.90	22.53	10.49
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	210.72	17.56	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	254.59	22.00	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	141.86	22.25	15.99
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	409.42	28.77	15.49
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	262.60	25.94	16.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	207.52	34.01	13.08
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	375.71	31.50	33.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	275.28	31.36	17.42
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	289.10	38.40	25.60
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	220.29	23.55	16.63
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	179.52	19.95	19.95
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	189.61	25.77	10.12
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	366.06	45.38	33.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	260.76	0.00	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	308.75	28.55	27.49
Keratinocyte - epidermal, donor1	11272-116H3	270.26	16.73	10.61
Keratinocyte - epidermal, donor2	11349-117G8	148.75	9.96	14.06
Keratinocyte - epidermal, donor3	11421-118F8	217.24	20.82	10.79
Keratinocyte - oral, donor1	11251-116E9	229.76	14.64	9.99
Keratocytes, donor1	11527-119I6	544.97	22.69	33.70
Keratocytes, donor2	11607-120I5	472.24	35.15	36.33
Keratocytes, donor3	11688-122I5	326.83	14.23	8.69
Krukenberg tumor cell line:HSKTC	10687-109F3	723.11	52.75	87.92
Lens Epithelial Cells, donor1	11529-119I8	268.61	22.65	32.36
Lens Epithelial Cells, donor2	11609-120I7	248.77	22.61	16.72
Lens Epithelial Cells, donor3	11690-122I7	210.90	29.36	21.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	355.02	39.01	29.53
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	336.56	48.56	40.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	344.26	61.08	40.77
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	416.73	59.69	45.71
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	383.56	60.51	34.98
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	368.40	66.09	46.14
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	351.71	48.84	38.58
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	399.71	52.84	48.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	368.91	59.82	42.08
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	340.55	46.28	38.37
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	354.61	51.57	42.46
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	358.26	59.06	46.47
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	373.16	45.64	40.07
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	337.75	47.70	33.87
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	372.76	63.32	43.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	369.24	48.97	39.42
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	390.30	57.67	38.34
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	408.44	76.31	41.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	369.92	53.97	45.75
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	404.16	54.18	41.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	455.79	67.46	54.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	379.73	44.62	42.19
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	334.47	49.01	36.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	371.48	65.70	44.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	431.32	49.77	48.73
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	310.32	46.69	27.85
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	365.25	59.70	46.77
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	387.27	55.72	41.96
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	318.35	39.70	28.79
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	373.86	70.40	41.03
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	341.14	43.13	41.67
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	350.64	43.99	29.77
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	358.91	59.10	41.26
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	400.20	62.94	47.39
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	338.01	45.22	35.09
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	381.68	59.95	46.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	347.69	50.82	41.81
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	354.54	45.35	27.39
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	342.64	53.19	39.33
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	360.54	52.98	39.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	413.03	45.57	32.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	399.76	57.42	40.61
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	406.81	48.70	45.84
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	322.75	38.87	22.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	385.86	70.39	45.91
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	321.63	35.15	25.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	319.90	37.39	27.92
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	399.80	52.21	52.21
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	290.05	70.25	52.12
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	356.72	84.38	61.37
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	266.46	54.92	52.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	365.58	81.24	63.47
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	325.64	62.60	62.60
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	298.87	66.31	43.90
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	337.50	79.35	70.59
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	306.88	67.80	65.42
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	201.31	52.70	45.01
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	457.18	104.41	85.21
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	371.84	76.53	69.78
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	215.69	53.79	40.78
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	385.14	89.87	64.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	339.09	71.63	67.04
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	359.14	49.31	57.97
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	354.53	78.95	67.24
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	350.58	68.30	69.64
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	454.60	87.29	79.73
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	382.25	80.38	74.85
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	339.22	67.68	63.60
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	406.49	87.46	77.05
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	472.24	102.58	90.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	317.34	72.12	55.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	400.33	80.99	73.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	477.99	99.54	81.31
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	392.26	84.65	70.82
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	311.78	71.76	58.68
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	450.28	86.29	74.49
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	358.05	74.83	61.02
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	359.19	80.97	74.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	355.53	79.26	71.33
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	338.85	64.82	54.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	305.47	64.17	60.55
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	448.84	96.95	60.32
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	365.98	73.94	71.70
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	308.05	90.30	63.17
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	451.42	91.75	69.35
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	308.27	75.35	56.52
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	338.84	80.96	74.30
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	386.72	85.67	73.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	287.24	64.70	59.01
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	331.34	76.99	69.77
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	398.80	64.95	64.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	264.63	64.64	49.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	341.15	68.53	60.75
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	386.09	81.41	59.31
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	283.48	67.70	58.18
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	326.92	80.43	54.42
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	391.78	63.24	59.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	295.88	79.72	70.52
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	308.30	79.91	64.62
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	376.37	67.75	73.39
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	271.02	63.86	63.86
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	321.29	64.44	59.48
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	401.02	51.63	63.68
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	287.25	69.92	63.68
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	286.62	64.91	55.53
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	368.13	72.57	58.72
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	296.31	65.90	66.42
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	299.30	68.70	57.76
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	392.49	60.94	72.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	283.09	64.48	63.60
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	340.59	87.17	69.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	401.03	80.00	62.28
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	317.21	63.44	52.87
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	335.53	64.80	52.48
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	444.17	75.35	62.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	332.02	74.70	76.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	332.87	70.68	64.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	420.88	70.75	68.17
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	304.14	56.84	71.35
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	331.16	81.44	68.77
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	464.85	74.63	80.50
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	329.86	76.43	75.86
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	356.36	79.19	71.99
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	451.29	65.08	67.91
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	356.38	67.53	81.72
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	322.42	73.22	64.07
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	408.75	66.56	60.29
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	325.69	67.64	78.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	344.30	75.74	61.80
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	392.06	78.28	95.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	365.16	73.25	94.10
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	318.83	84.46	72.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	412.99	80.76	67.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	328.97	67.57	101.36
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	312.86	75.79	68.95
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	374.25	81.29	71.32
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	367.16	74.96	83.72
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	302.01	71.27	60.14
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	234.22	56.15	52.77
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	403.83	88.19	98.14
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	465.61	64.44	66.52
Macrophage - monocyte derived, donor1	11232-116C8	154.30	30.54	22.11
Macrophage - monocyte derived, donor2	11313-117C8	152.49	28.44	26.43
Macrophage - monocyte derived, donor3	11389-118C3	213.14	39.32	36.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	262.32	37.70	29.74
Mallassez-derived cells, donor2	11929-125I3	369.83	38.19	33.12
Mallassez-derived cells, donor3	11930-125I4	377.77	36.97	35.86
Mammary Epithelial Cell, donor1	11273-116H4	334.30	24.51	14.25
Mammary Epithelial Cell, donor2	11350-117G9	293.02	17.08	15.06
Mammary Epithelial Cell, donor3	11422-118F9	147.41	21.20	15.71
Mast cell - stimulated, donor1	11487-119E2	256.26	26.44	24.41
Mast cell, donor1	11563-120D6	254.02	32.01	33.09
Mast cell, donor2	11565-120D8	281.42	31.80	28.83
Mast cell, donor3	11566-120D9	300.32	32.87	32.87
Mast cell, donor4	11567-120E1	245.90	30.32	24.11
Mast cell, expanded and stimulated, donor5	11940-126A5	336.67	35.49	37.59
Mast cell, expanded and stimulated, donor8	11942-126A7	581.35	35.60	46.11
Mast cell, expanded, donor5	11939-126A4	308.37	33.73	32.35
Mast cell, expanded, donor8	11941-126A6	270.30	29.12	24.10
Melanocyte - dark, donor1	11502-119F8	255.31	34.72	23.18
Melanocyte - dark, donor2	11582-120F7	277.56	24.57	26.65
Melanocyte - dark, donor3	11663-122F7	220.65	37.67	23.04
Melanocyte - light, donor1	11274-116H5	91.91	11.05	6.58
Melanocyte - light, donor2	11351-117H1	126.26	22.52	17.06
Melanocyte - light, donor3	11423-118G1	153.50	16.48	18.21
Melanocyte, donor1 (MC+1)	12641-134G4	198.57	37.69	26.34
Melanocyte, donor2 (MC+2)	12739-135I3	222.42	37.92	27.43
Melanocyte, donor3 (MC+3)	12837-137B2	224.73	25.71	19.02
Meningeal Cells, donor1	11493-119E8	336.33	24.44	19.48
Meningeal Cells, donor2	11573-120E7	438.39	33.45	40.49
Meningeal Cells, donor3	11654-122E7	246.22	25.10	18.34
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	320.52	32.22	21.10
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	212.43	20.93	16.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	434.99	13.14	11.83
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	541.58	45.79	22.24
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	341.58	28.70	17.94
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	237.82	21.81	19.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	381.01	42.72	42.22
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	394.90	30.33	24.83
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	572.78	50.41	43.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	474.06	38.06	38.06
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	352.50	16.76	17.31
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	450.90	24.53	24.91
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	269.33	18.29	13.95
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	465.88	30.56	29.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	623.59	30.36	44.38
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	468.13	37.78	26.26
Mesenchymal stem cells - adipose, donor0	11217-116B2	292.06	31.19	26.23
Mesenchymal stem cells - hepatic, donor0	11218-116B3	247.05	21.58	16.26
Mesenchymal stem cells - umbilical, donor0	11214-116A8	320.76	37.74	31.93
Mesothelial Cells, donor1	11247-116E5	264.91	38.19	31.56
Mesothelial Cells, donor2	12156-128G5	263.25	39.54	24.02
Mesothelial Cells, donor3	11402-118D7	211.81	28.54	19.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	271.42	24.31	36.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	290.60	47.78	43.84
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	217.90	46.52	45.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	162.48	20.74	31.11
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	218.51	26.35	34.71
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	193.33	32.36	34.43
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	169.07	25.48	18.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	269.28	41.29	42.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	224.83	44.69	38.17
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	311.46	0.00	77.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	234.51	42.68	37.39
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	195.61	37.62	32.86
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	188.13	42.76	51.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	208.85	29.20	23.89
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	234.80	56.99	38.75
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	169.75	17.11	23.69
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	214.98	39.05	30.56
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	183.24	41.44	18.42
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	191.35	28.32	31.59
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	174.37	25.15	18.44
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	271.59	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	218.03	33.37	31.61
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	168.27	31.37	28.28
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	154.25	21.01	21.56
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	191.56	26.48	32.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	176.26	38.28	30.92
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	142.68	27.92	22.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	196.52	31.32	29.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	155.16	33.79	22.23
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	175.41	0.00	20.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	168.20	31.32	22.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	177.94	26.87	22.81
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	164.04	26.51	28.17
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	203.30	27.99	27.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	183.21	32.35	24.70
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	195.17	25.08	32.71
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	169.64	31.24	35.56
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	223.73	40.02	37.62
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	197.46	41.14	27.42
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	197.73	33.54	34.54
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	53.89	80.84
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	156.96	36.69	26.50
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	275.01	45.54	47.73
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	241.70	46.35	34.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	187.63	33.94	37.14
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	297.50	57.02	50.82
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	233.82	25.75	37.58
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	236.46	33.15	26.52
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	276.58	47.18	50.26
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	222.31	31.95	45.95
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	209.86	59.30	52.20
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	301.03	68.45	59.76
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	215.71	36.58	39.07
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	198.72	47.20	34.96
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	238.92	54.30	44.34
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	233.74	42.99	41.32
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	231.00	36.09	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	290.00	71.11	53.57
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	348.87	54.64	64.88
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	187.24	56.38	40.07
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	236.08	58.83	52.09
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	326.02	47.62	57.48
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	181.66	41.92	32.39
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	235.93	44.30	42.70
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	313.40	60.46	55.08
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	150.15	43.93	39.97
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	276.47	58.61	54.47
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	307.81	64.79	64.35
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	183.91	54.98	37.16
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	222.17	53.98	49.15
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	312.42	67.60	55.31
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	182.47	41.71	27.37
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	233.75	42.63	37.34
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	331.00	61.13	57.67
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	230.39	30.50	19.37
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	229.29	43.48	41.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	316.42	64.04	37.67
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	304.76	21.39	32.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	227.04	33.19	25.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	285.08	38.92	31.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	185.23	24.51	18.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	234.69	22.35	22.35
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	289.53	51.45	32.67
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	254.62	45.81	36.49
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	175.31	26.58	20.36
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	296.90	31.68	26.52
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	215.09	35.18	26.38
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	216.23	24.89	32.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	205.22	38.48	31.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	278.20	38.64	30.91
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	266.62	25.25	25.25
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	227.26	38.37	32.04
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	187.95	25.88	29.96
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	279.75	26.07	29.25
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	270.49	41.30	39.68
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	178.23	51.35	28.70
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	205.57	34.26	34.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	251.21	29.36	42.41
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	161.58	42.77	33.27
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	250.98	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	300.53	36.62	30.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	486.55	56.44	58.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	172.88	23.36	19.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	166.95	25.46	21.70
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	307.08	42.97	37.27
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1121.88	110.11	138.84
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	157.07	14.28	13.60
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	376.72	29.40	45.94
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	156.11	15.49	12.14
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	236.85	35.10	21.62
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	135.38	11.35	14.32
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	405.97	39.52	37.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	356.31	33.40	100.21
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	195.07	19.85	23.83
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	319.39	34.10	25.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	154.14	18.13	11.33
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	176.20	12.25	11.59
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	369.25	28.25	32.44
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	215.89	28.64	22.28
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	163.28	15.01	15.01
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	413.17	42.99	49.88
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	138.23	17.40	11.71
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	487.17	43.92	42.51
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	200.42	26.72	24.61
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	253.76	25.28	20.23
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	205.98	18.00	17.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	326.95	46.90	42.77
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	477.88	53.10	42.98
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	390.10	26.96	36.54
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	252.76	35.14	19.48
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	396.61	41.06	37.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	195.31	18.03	16.31
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	243.75	72.22	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	181.94	15.33	15.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	458.08	30.21	37.87
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	235.70	22.62	25.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	229.38	13.00	26.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	280.00	28.00	25.73
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	153.82	19.23	14.34
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	133.79	9.15	16.12
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	485.30	50.20	54.27
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	155.22	18.52	22.05
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	192.81	15.96	11.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	201.39	18.85	18.35
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	133.61	16.08	15.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	286.72	30.24	23.89
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	396.30	29.40	33.82
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	182.97	16.94	15.59
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	378.11	40.88	30.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	253.63	19.51	15.85
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	153.28	12.27	15.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	127.42	9.08	5.75
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	203.32	17.41	13.45
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	401.31	48.75	60.08
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	531.08	65.75	30.35
Myoblast, donor1	11241-116D8	304.48	42.98	30.19
Myoblast, donor2	11322-117D8	383.96	46.99	35.48
Myoblast, donor3	11398-118D3	227.02	29.43	20.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	316.82	55.16	31.67
Natural Killer Cells, donor1	11230-116C6	296.75	43.67	26.75
Natural Killer Cells, donor2	11311-117C6	342.57	46.14	37.09
Natural Killer Cells, donor3	11387-118C1	258.78	36.07	24.66
Neural stem cells, donor1	11275-116H6	398.14	37.75	29.04
Neural stem cells, donor2	11352-117H2	252.26	19.26	5.78
Neurons, donor1	11494-119E9	615.60	60.31	40.96
Neurons, donor2	11574-120E8	303.38	28.18	22.90
Neurons, donor3	11655-122E8	764.61	64.95	57.55
Neutrophils, donor1	11233-116C9	55.68	10.21	12.99
Neutrophils, donor2	11314-117C9	52.18	8.70	5.80
Neutrophils, donor3	11390-118C4	87.35	5.50	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	304.56	19.83	13.54
Nucleus Pulposus Cell, donor2	11409-118E5	404.07	27.35	19.21
Nucleus Pulposus Cell, donor3	11462-119B4	457.26	29.88	31.09
Olfactory epithelial cells, donor1	11933-125I7	480.82	70.20	45.84
Olfactory epithelial cells, donor2	11934-125I8	555.39	76.14	54.28
Olfactory epithelial cells, donor3	11935-125I9	504.87	64.47	45.29
Olfactory epithelial cells, donor4	11936-126A1	587.01	61.26	35.65
Oligodendrocyte - precursors, donor1	11496-119F2	260.59	40.92	24.07
Osteoblast - differentiated, donor1	11276-116H7	300.75	23.82	21.69
Osteoblast - differentiated, donor2	11353-117H3	278.92	35.44	24.01
Osteoblast - differentiated, donor3	11425-118G3	236.49	21.10	12.41
Osteoblast, donor1	11277-116H8	361.95	49.64	29.90
Osteoblast, donor2	11354-117H4	280.22	27.39	17.56
Osteoblast, donor3	11426-118G4	336.09	46.21	21.86
Pancreatic stromal cells, donor1	11249-116E7	244.87	25.61	16.68
Pericytes, donor1	11491-119E6	427.49	31.82	30.60
Pericytes, donor2	11571-120E5	612.09	52.74	62.70
Pericytes, donor3	11652-122E5	458.98	46.79	38.25
Perineurial Cells, donor1	11499-119F5	257.69	21.59	15.71
Perineurial Cells, donor2	11579-120F4	188.99	18.95	12.15
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	318.42	31.87	24.86
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	293.59	33.06	26.45
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	275.91	26.66	25.62
Placental Epithelial Cells, donor1	11278-116H9	244.43	45.92	23.92
Placental Epithelial Cells, donor2	11355-117H5	266.13	27.72	21.07
Placental Epithelial Cells, donor3	11427-118G5	233.24	30.82	20.22
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	227.21	35.44	22.78
Preadipocyte - breast, donor1	11467-119B9	287.95	29.08	16.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	265.23	35.63	27.02
Preadipocyte - breast, donor2	11328-117E5	381.18	44.35	32.20
Preadipocyte - omental, donor1	11468-119C1	282.49	23.66	21.95
Preadipocyte - omental, donor2	11329-117E6	225.22	25.32	20.51
Preadipocyte - omental, donor3	11403-118D8	295.95	46.84	28.94
Preadipocyte - perirenal, donor1	11469-119C2	387.80	60.04	56.10
Preadipocyte - subcutaneous, donor1	11279-116I1	215.90	31.63	19.66
Preadipocyte - subcutaneous, donor2	11356-117H6	420.56	41.26	29.93
Preadipocyte - subcutaneous, donor3	11428-118G6	320.99	37.97	21.80
Preadipocyte - visceral, donor1	11280-116I2	299.93	27.85	16.77
Preadipocyte - visceral, donor2	11357-117H7	441.31	38.19	24.39
Preadipocyte - visceral, donor3	11429-118G7	412.74	52.25	33.75
Prostate Epithelial Cells (polarized), donor1	11253-116F2	227.03	45.71	34.09
Prostate Epithelial Cells, donor2	11331-117E8	278.27	35.48	26.81
Prostate Epithelial Cells, donor3	11404-118D9	246.73	13.47	10.29
Prostate Stromal Cells, donor1	11254-116F3	287.14	33.94	20.96
Prostate Stromal Cells, donor2	11332-117E9	540.41	47.33	41.42
Prostate Stromal Cells, donor3	11405-118E1	354.23	35.56	26.49
Renal Cortical Epithelial Cells, donor1	11516-119H4	399.66	33.21	24.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	274.13	21.63	16.63
Renal Epithelial Cells, donor1	11517-119H5	441.80	34.49	23.84
Renal Epithelial Cells, donor2	11597-120H4	532.78	63.31	41.97
Renal Epithelial Cells, donor3	11678-122H4	269.74	20.11	13.66
Renal Glomerular Endothelial Cells, donor1	11514-119H2	441.87	53.79	53.11
Renal Glomerular Endothelial Cells, donor2	11594-120H1	407.26	42.32	38.41
Renal Glomerular Endothelial Cells, donor3	11675-122H1	361.66	45.07	36.63
Renal Glomerular Endothelial Cells, donor4	11783-124B1	517.71	39.93	52.57
Renal Mesangial Cells, donor1	11518-119H6	384.05	31.03	24.43
Renal Mesangial Cells, donor2	11598-120H5	464.60	44.52	30.10
Renal Mesangial Cells, donor3	11679-122H5	420.83	38.01	25.80
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	421.42	37.85	30.60
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	535.97	61.99	57.77
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	393.22	40.50	32.01
Retinal Pigment Epithelial Cells, donor0	11215-116A9	264.99	27.48	17.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	311.53	31.27	25.58
Retinal Pigment Epithelial Cells, donor2	11608-120I6	412.68	41.16	38.08
Retinal Pigment Epithelial Cells, donor3	11689-122I6	421.78	20.57	20.57
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	323.26	42.36	32.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	457.42	47.35	39.31
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	295.55	39.63	40.18
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	460.56	44.08	44.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	277.99	31.08	33.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	274.78	49.06	45.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	253.31	36.36	31.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	261.36	34.73	41.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	289.38	56.87	42.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	339.99	51.08	45.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	256.43	32.86	35.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	276.53	44.93	39.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	224.88	32.97	31.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	281.17	41.32	39.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	270.86	46.04	35.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	302.70	55.10	43.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	259.62	37.09	46.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	254.80	49.47	34.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	249.54	33.26	24.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	309.47	37.82	45.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	258.73	52.76	32.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	288.73	47.36	38.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	274.57	36.84	42.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	322.63	44.29	35.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	295.14	45.97	35.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	317.62	36.65	41.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	265.25	50.40	39.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	281.80	48.89	41.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	326.21	40.10	45.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	285.91	48.61	35.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	324.34	55.66	47.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	282.42	35.25	42.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	359.91	55.52	48.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	292.44	48.46	39.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	287.20	39.30	40.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	307.89	51.60	43.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	280.71	54.95	43.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	278.54	38.34	41.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	275.85	54.04	38.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	298.13	50.40	42.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	267.58	39.20	43.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	251.97	62.14	42.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	300.40	45.05	41.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	333.50	35.81	37.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	283.82	46.19	34.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	331.33	46.56	38.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	284.88	31.08	38.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	384.30	47.51	53.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	326.09	54.40	49.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	322.98	40.88	42.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	251.66	35.08	26.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	343.76	47.46	45.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	316.77	44.61	51.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	281.15	40.26	36.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	312.42	38.04	32.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	276.41	31.64	35.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	263.18	43.76	35.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	235.58	25.84	22.24
Schwann Cells, donor1	11498-119F4	605.40	55.29	49.65
Schwann Cells, donor2	11578-120F3	306.22	23.82	27.22
Schwann Cells, donor3	11659-122F3	281.74	31.11	25.85
Sebocyte, donor1	11220-116B5	163.24	21.36	13.69
Sebocyte, donor2	11301-117B5	295.03	30.79	20.68
Sebocyte, donor3	11378-118B1	286.50	29.06	18.76
Sertoli Cells, donor1	11255-116F4	291.56	41.41	34.79
Sertoli Cells, donor2	11333-117F1	638.31	62.14	50.84
Skeletal Muscle Cells, donor1	11281-116I3	351.12	29.03	21.29
Skeletal Muscle Cells, donor2	11358-117H8	271.79	46.98	24.58
Skeletal Muscle Cells, donor3	11430-118G8	342.78	40.97	30.93
Skeletal Muscle Cells, donor4	11451-119A2	316.86	30.16	22.94
Skeletal Muscle Cells, donor5	11455-119A6	301.30	25.12	20.96
Skeletal Muscle Cells, donor6	11459-119B1	340.43	34.94	24.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	281.25	20.54	14.62
Skeletal Muscle Satellite Cells, donor2	11321-117D7	336.89	21.40	16.55
Skeletal Muscle Satellite Cells, donor3	11397-118D2	298.62	31.25	19.54
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	325.38	33.20	23.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	333.65	31.85	31.12
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	276.85	39.35	29.03
Skin - palm, donor1	10286-104F7	846.12	94.01	67.15
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	197.35	25.66	22.34
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	372.14	33.53	28.63
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	195.65	18.44	19.21
Small Airway Epithelial Cells, donor1	11256-116F5	343.07	30.30	23.91
Small Airway Epithelial Cells, donor2	11334-117F2	352.49	47.54	38.12
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	219.48	22.84	18.82
Small Airway Epithelial Cells, donor3	11406-118E2	289.46	24.81	19.41
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	566.87	47.52	50.30
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	299.26	32.24	31.13
Smooth Muscle Cells - Aortic, donor0	11210-116A4	226.90	39.38	20.57
Smooth Muscle Cells - Aortic, donor1	11283-116I5	207.29	29.17	17.46
Smooth Muscle Cells - Aortic, donor2	11360-117I1	356.76	43.71	25.99
Smooth Muscle Cells - Aortic, donor3	11432-118H1	247.22	31.68	17.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	454.34	27.02	23.02
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	247.79	41.65	25.02
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	425.80	54.53	41.45
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	547.84	67.73	55.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	228.56	28.98	19.21
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	207.61	24.81	19.79
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	227.50	21.78	17.51
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	387.65	24.08	19.20
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	372.02	18.57	23.14
Smooth Muscle Cells - Carotid, donor1	11285-116I7	182.35	35.11	22.23
Smooth Muscle Cells - Carotid, donor2	11362-117I3	140.78	48.97	36.72
Smooth Muscle Cells - Carotid, donor3	11434-118H3	339.03	43.39	39.10
Smooth Muscle Cells - Colonic, donor1	11239-116D6	213.39	18.29	12.68
Smooth Muscle Cells - Colonic, donor2	11320-117D6	286.48	22.82	16.57
Smooth Muscle Cells - Colonic, donor3	11396-118D1	232.59	26.76	16.69
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	312.14	47.33	31.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	496.90	61.44	45.27
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	309.91	37.95	34.37
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	433.24	29.70	19.80
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	253.26	13.19	9.89
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	347.41	41.46	28.18
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	459.66	60.30	40.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	479.43	36.23	34.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	274.46	28.88	15.90
Smooth Muscle Cells - Prostate, donor1	11257-116F6	380.04	31.83	32.89
Smooth Muscle Cells - Prostate, donor2	11335-117F3	384.42	34.81	25.29
Smooth Muscle Cells - Prostate, donor3	11465-119B7	254.68	22.07	13.44
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	282.25	34.53	21.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	289.56	30.01	18.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	308.84	45.23	23.26
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	228.81	35.81	26.04
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	494.28	60.59	47.96
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	317.47	60.49	42.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	238.36	17.11	17.70
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	252.09	26.82	18.24
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	297.11	17.75	13.55
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	210.26	47.06	23.75
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	276.63	49.72	28.05
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	323.98	46.63	29.90
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	220.38	15.65	13.83
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	249.02	17.60	12.07
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	498.09	10.00	12.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	206.74	44.53	26.42
Smooth Muscle Cells - Uterine, donor1	11258-116F7	494.70	35.35	29.17
Smooth Muscle Cells - Uterine, donor3	11466-119B8	277.36	23.70	16.97
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	445.09	30.90	23.91
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	487.65	54.74	45.22
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	413.60	36.08	25.66
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	528.94	41.68	36.29
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	376.17	47.98	41.17
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	484.06	50.81	44.90
Smooth muscle cells - airway, control, donor1	11966-126D4	460.41	45.20	27.17
Smooth muscle cells - airway, control, donor2	11967-126D5	417.29	24.36	25.56
Smooth muscle cells - airway, control, donor3	11968-126D6	636.20	38.87	30.10
Smooth muscle cells - airway, control, donor4	11969-126D7	616.50	34.84	33.00
Synoviocyte, donor1	11291-117A4	406.66	49.49	33.66
Synoviocyte, donor2	11368-117I9	378.16	52.80	30.68
Synoviocyte, donor3	11440-118H9	497.53	49.60	41.55
Trabecular Meshwork Cells, donor1	11532-120A2	459.53	31.45	25.73
Trabecular Meshwork Cells, donor2	11612-122A1	636.23	27.75	27.75
Trabecular Meshwork Cells, donor3	11693-123A1	438.09	30.80	30.33
Tracheal Epithelial Cells, donor1	11292-117A5	210.47	14.62	9.89
Tracheal Epithelial Cells, donor2	11369-118A1	165.06	19.71	14.30
Tracheal Epithelial Cells, donor3	11441-118I1	256.55	25.20	22.91
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	321.46	39.49	29.28
Urethra, donor2	10319-105A4	579.09	59.35	53.95
Urothelial Cells, donor1	11520-119H8	325.70	21.52	21.52
Urothelial Cells, donor2	11600-120H7	329.26	23.63	19.63
Urothelial Cells, donor3	11681-122H7	276.42	15.36	13.52
Urothelial cells, donor0	11216-116B1	222.23	11.59	8.69
Whole blood (ribopure), donor090309, donation1	12179-129A1	345.24	14.24	41.82
Whole blood (ribopure), donor090309, donation2	12180-129A2	431.74	24.30	40.03
Whole blood (ribopure), donor090309, donation3	12181-129A3	290.92	30.80	36.28
Whole blood (ribopure), donor090325, donation1	12176-128I7	301.98	27.89	22.73
Whole blood (ribopure), donor090325, donation2	12177-128I8	331.19	21.50	31.38
Whole blood (ribopure), donor090612, donation1	12182-129A4	326.95	17.70	27.07
Whole blood (ribopure), donor090612, donation2	12183-129A5	357.94	19.27	34.88
Whole blood (ribopure), donor090612, donation3	12184-129A6	287.56	23.74	35.60
Wilms' tumor cell line:G-401	10809-111A8	288.17	40.22	31.21
Wilms' tumor cell line:HFWT	10597-108E3	507.78	28.16	32.56
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	313.67	29.89	15.36
achilles tendon, donor2	10292-104G4	471.17	43.40	45.46
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	345.98	63.99	37.22
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	332.94	49.45	32.97
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	279.91	23.15	15.55
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	414.16	66.94	52.79
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	332.24	60.43	44.13
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	283.60	79.09	45.47
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	387.90	49.54	41.38
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	495.72	44.50	48.03
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	390.80	47.37	49.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	457.80	72.61	58.24
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	347.02	36.43	34.22
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	468.06	78.01	66.31
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	388.77	58.56	61.12
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	752.63	76.12	76.12
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	376.12	36.24	28.35
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	426.18	66.46	57.17
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	399.74	28.38	39.48
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	278.40	38.06	35.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	417.32	45.66	45.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	351.21	38.52	33.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	385.13	41.64	40.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	253.70	53.46	38.76
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	364.57	41.03	34.02
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	895.65	68.75	74.33
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	347.66	41.06	40.30
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	427.85	68.04	64.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	431.13	84.35	56.23
adenocarcinoma cell line:IM95m	10796-110I4	368.56	53.22	37.44
adipose tissue, adult, pool1	10010-101C1	210.03	11.17	11.94
adipose, donor1	10184-103D4	792.83	86.20	66.26
adipose, donor2	10185-103D5	810.23	49.47	39.74
adipose, donor3	10186-103D6	609.65	69.16	52.01
adipose, donor4	10187-103D7	487.98	63.27	57.21
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	268.14	19.41	13.57
adrenal gland, adult, pool1	10081-102A9	356.49	36.38	18.19
adult T-cell leukemia cell line:ATN-1	10421-106C7	231.86	11.61	10.94
alveolar cell carcinoma cell line:SW 1573	10708-109H6	504.86	47.88	38.95
amniotic membrane cells, donor1	12235-129G3	170.64	27.36	28.75
amniotic membrane cells, donor2	12236-129G4	261.35	32.46	19.61
amniotic membrane cells, donor3	12237-129G5	253.36	41.54	44.78
amygdala - adult, donor10196	10167-103B5	356.93	71.15	47.43
amygdala, adult, donor10252	10151-102I7	326.86	63.47	42.58
amygdala, newborn, donor10223	10360-105E9	324.06	45.51	41.31
anaplastic carcinoma cell line:8305C	10428-106D5	530.20	31.45	33.87
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	484.05	82.29	44.79
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	339.05	21.04	19.04
aorta, adult, pool1	10052-101G7	368.14	37.66	28.83
appendix, adult	10189-103D9	390.06	48.90	41.92
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	491.48	65.69	45.74
artery, adult	10190-103E1	365.49	50.27	29.89
astrocytoma cell line:TM-31	10425-106D2	357.39	30.57	34.48
b cell line:RPMI1788	10427-106D4	290.12	24.54	16.36
basal cell carcinoma cell line:TE 354.T	10702-109G9	298.26	43.00	34.40
bile duct carcinoma cell line:HuCCT1	10432-106D9	269.31	40.78	27.69
bile duct carcinoma cell line:TFK-1	10496-107C1	282.37	34.48	29.63
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	506.11	53.69	42.50
bladder, adult, pool1	10011-101C2	281.16	11.84	12.06
blood, adult, pool1	10053-101G8	294.55	33.22	31.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	322.84	41.10	25.69
bone marrow, adult	10192-103E3	433.24	28.34	36.44
brain, adult, donor1	10084-102B3	290.09	53.30	39.98
brain, adult, pool1	10012-101C3	239.31	55.90	31.74
brain, fetal, pool1	10085-102B4	745.32	34.73	61.44
breast carcinoma cell line:MCF7	10482-107A5	970.94	180.05	142.39
breast carcinoma cell line:MDA-MB-453	10419-106C5	566.95	74.64	55.92
breast, adult, donor1	10080-102A8	306.84	12.63	20.20
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	236.93	31.63	44.08
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	486.09	79.47	62.77
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	279.49	17.27	16.12
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	331.17	78.19	53.74
carcinoid cell line:NCI-H1770	10703-109H1	550.57	39.96	21.63
carcinoid cell line:NCI-H727	10735-110B6	279.03	48.13	42.33
carcinoid cell line:SK-PN-DW	10719-109I8	465.20	22.50	19.65
carcinosarcoma cell line:JHUCS-1	10642-109A3	865.61	59.62	47.38
caudate nucleus - adult, donor10196	10177-103C6	283.23	43.75	41.45
caudate nucleus, adult, donor10252	10164-103B2	295.67	46.68	35.47
caudate nucleus, adult, donor10258	10379-105H1	363.73	51.20	64.95
caudate nucleus, newborn, donor10223	10354-105E3	410.55	47.24	38.82
cerebellum - adult, donor10196	10173-103C2	483.60	61.18	43.70
cerebellum, adult, donor10252	10166-103B4	362.11	89.46	72.38
cerebellum, adult, pool1	10083-102B2	309.76	85.89	55.88
cerebellum, newborn, donor10223	10357-105E6	557.12	59.78	75.56
cerebral meninges, adult	10188-103D8	326.52	80.43	54.97
cerebrospinal fluid, donor2	10294-104G6	510.89	52.62	48.97
cervical cancer cell line:D98-AH2	10552-107I3	445.44	49.17	35.23
cervical cancer cell line:ME-180	10553-107I4	509.08	74.41	54.36
cervix, adult, pool1	10013-101C4	344.16	24.99	19.95
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	332.88	44.03	41.52
chondrosarcoma cell line:SW 1353	10700-109G7	467.64	45.72	24.82
choriocarcinoma cell line:BeWo	10423-106C9	626.23	60.52	35.79
choriocarcinoma cell line:SCH	10785-110H2	1012.19	128.76	125.80
choriocarcinoma cell line:T3M-3	10618-108G6	1269.61	92.26	109.10
chorionic membrane cells, donor1	12238-129G6	142.46	23.08	21.65
chorionic membrane cells, donor2	12239-129G7	233.37	33.31	19.89
chorionic membrane cells, donor3	12240-129G8	237.93	31.32	30.77
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	354.44	51.50	44.43
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	569.00	84.72	62.62
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	543.17	84.47	71.38
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	404.72	16.95	18.49
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	440.22	22.98	25.40
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	387.27	19.95	15.27
chronic myelogenous leukemia cell line:K562	10454-106G4	615.41	33.27	34.16
chronic myelogenous leukemia cell line:KU812	10409-106B4	228.57	37.01	21.37
clear cell carcinoma cell line:JHOC-5	10638-108I8	372.36	32.92	26.74
clear cell carcinoma cell line:TEN	10636-108I6	348.40	34.70	33.31
colon carcinoma cell line:CACO-2	10513-107D9	220.93	50.70	35.88
colon carcinoma cell line:COLO-320	10420-106C6	292.28	9.88	8.74
colon, adult, donor1	10082-102B1	346.30	45.22	45.22
colon, adult, pool1	10014-101C5	379.65	65.92	48.41
colon, fetal, donor1	10070-101I7	434.45	59.33	43.88
common myeloid progenitor CMP, donor1	12130-128D6	197.09	45.84	18.33
common myeloid progenitor CMP, donor2	12134-128E1	475.70	125.18	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	364.59	29.32	23.37
cord blood derived cell line:COBL-a 24h infection	10453-106G3	341.11	41.51	37.28
cord blood derived cell line:COBL-a untreated	10449-106F8	359.86	44.56	35.96
corpus callosum, adult, pool1	10042-101F6	250.53	30.52	30.29
cruciate ligament, donor2	10295-104G7	446.57	41.33	32.42
diaphragm, fetal, donor1	10069-101I6	351.52	40.13	54.57
diencephalon, adult	10193-103E4	307.43	39.36	44.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	442.69	87.48	45.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	541.09	51.29	44.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	353.86	30.33	19.74
ductus deferens, adult	10196-103E7	382.23	66.78	61.79
duodenum, fetal, donor1, tech_rep1	10071-101I8	571.77	76.33	76.33
duodenum, fetal, donor1, tech_rep2	10071-101I8	664.29	63.27	87.54
dura mater, adult, donor1	10041-101F5	187.56	20.23	14.70
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	599.15	36.20	23.54
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	497.66	26.37	18.34
embryonic pancreas cell line:1B2C6	10604-108F1	986.58	63.51	74.61
embryonic pancreas cell line:1C3D3	10605-108F2	482.82	25.43	23.31
embryonic pancreas cell line:1C3IKEI	10606-108F3	725.56	48.16	48.47
embryonic pancreas cell line:2C6	10603-108E9	1024.50	47.28	68.30
endometrial carcinoma cell line:OMC-2	10497-107C2	261.79	25.81	25.81
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	536.46	38.60	38.60
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	465.55	73.17	58.38
epidermoid carcinoma cell line:A431	10426-106D3	278.01	32.35	21.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	208.31	34.65	22.99
epididymis, adult	10197-103E8	311.45	50.23	46.68
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	412.30	31.05	27.85
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	330.72	32.64	37.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	474.53	81.78	66.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	392.50	61.71	58.76
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	470.97	81.11	73.49
esophagus, adult, pool1	10015-101C6	291.35	26.97	18.37
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	351.16	21.04	19.16
eye - muscle inferior rectus, donor1	10272-104E2	581.91	65.19	45.88
eye - muscle lateral, donor2	10298-104H1	624.95	77.86	61.02
eye - muscle medial, donor2	10299-104H2	489.62	46.13	84.83
eye - muscle superior, donor2	10297-104G9	492.99	56.18	58.47
eye - vitreous humor, donor1	10268-104D7	303.14	71.41	39.35
eye, fetal, donor1	10054-101G9	370.93	39.15	42.20
fibrosarcoma cell line:HT-1080	10758-110E2	233.62	34.11	19.62
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	311.02	39.17	28.25
frontal lobe, adult, pool1	10040-101F4	218.42	48.04	32.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	414.94	94.58	71.16
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	185.80	7.86	8.87
gall bladder, adult	10198-103E9	335.11	42.01	45.87
gamma delta positive T cells, donor1	11937-126A2	471.90	55.30	44.02
gamma delta positive T cells, donor2	11938-126A3	384.70	54.90	40.34
gastric adenocarcinoma cell line:MKN1	10614-108G2	389.06	56.82	43.93
gastric adenocarcinoma cell line:MKN45	10612-108F9	703.65	64.60	87.04
gastric cancer cell line:AZ521	10549-107H9	350.37	30.17	26.23
gastric cancer cell line:GSS	10560-108A2	387.14	11.90	12.81
gastrointestinal carcinoma cell line:ECC12	10615-108G3	509.00	70.36	61.23
giant cell carcinoma cell line:LU65	10487-107B1	133.67	8.72	5.28
giant cell carcinoma cell line:Lu99B	10433-106E1	641.01	22.39	21.55
glassy cell carcinoma cell line:HOKUG	10688-109F4	515.55	74.33	65.85
glioblastoma cell line:A172, tech_rep1	10444-106F3	511.61	70.30	55.20
glioblastoma cell line:A172, tech_rep2	10444-106F3	597.57	82.72	68.53
glioblastoma cell line:T98G	10485-107A8	227.48	19.09	13.58
glioma cell line:GI-1	10413-106B8	167.53	16.40	12.89
globus pallidus - adult, donor10196	10175-103C4	437.35	49.57	48.84
globus pallidus, adult, donor10252	10161-103A8	356.38	31.49	32.71
globus pallidus, adult, donor10258	10367-105F7	703.77	98.58	98.58
globus pallidus, newborn, donor10223	10364-105F4	408.21	45.83	35.17
granulocyte macrophage progenitor, donor1	12131-128D7	305.89	48.94	24.47
granulocyte macrophage progenitor, donor2	12135-128E2	360.64	76.50	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	533.11	78.40	41.81
granulosa cell tumor cell line:KGN	10624-108H3	379.51	51.84	30.40
hIPS +CCl2, biol_rep1	14383-156B9	593.63	61.52	50.50
hIPS +CCl2, biol_rep2	14384-156C1	517.16	55.79	42.07
hIPS +CCl2, biol_rep3	14385-156C2	655.04	81.80	62.48
hIPS, biol_rep1	14380-156B6	682.71	47.43	74.74
hIPS, biol_rep2	14381-156B7	564.47	76.13	58.30
hIPS, biol_rep3	14382-156B8	393.94	41.93	76.14
hairy cell leukemia cell line:Mo	10712-109I1	491.36	55.74	42.24
heart - mitral valve, adult	10205-103F7	291.49	36.18	39.46
heart - pulmonic valve, adult	10206-103F8	363.45	49.94	37.13
heart - tricuspid valve, adult	10207-103F9	322.23	39.97	49.13
heart, adult, diseased post-infarction, donor1	10050-101G5	369.55	64.28	45.10
heart, adult, diseased, donor1	10051-101G6	492.26	74.09	53.65
heart, adult, pool1	10016-101C7	258.95	33.81	34.04
heart, fetal, pool1	10046-101G1	314.10	35.32	35.01
hepatic mesenchymal tumor cell line:LI90	10778-110G4	375.17	37.95	25.30
hepatoblastoma cell line:HuH-6	10633-108I3	671.88	96.32	82.05
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	354.80	81.88	52.71
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	322.85	76.95	46.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	336.61	73.47	45.78
hepatoma cell line:Li-7	10484-107A7	460.43	52.72	37.59
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	282.91	66.03	32.36
hippocampus - adult, donor10196	10169-103B7	385.16	63.40	52.99
hippocampus, adult, donor10252	10153-102I9	307.99	54.90	37.35
hippocampus, adult, donor10258	10374-105G5	334.62	59.75	61.25
hippocampus, newborn, donor10223	10363-105F3	342.96	40.89	31.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	742.79	119.02	73.85
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	501.69	62.83	45.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	563.39	76.42	47.99
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	669.31	48.49	30.45
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	591.82	47.25	34.60
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	646.85	43.66	32.27
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	693.68	53.72	52.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	528.45	40.72	35.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	789.52	74.66	60.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	459.14	51.38	41.91
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	603.01	66.54	56.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	440.34	46.46	48.48
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	404.98	59.62	38.34
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	520.28	77.13	49.62
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	699.95	98.62	57.60
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	516.80	43.72	31.88
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	514.13	34.01	28.78
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	750.14	57.97	52.47
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	549.35	35.79	24.30
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	682.53	44.11	40.02
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	875.18	56.07	37.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	515.05	64.01	54.05
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	498.17	68.22	58.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	671.08	82.20	63.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	517.47	66.32	48.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	473.57	67.04	48.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	670.45	117.19	73.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	509.11	46.83	35.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	427.60	25.66	26.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	522.02	45.39	32.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	504.19	49.64	41.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	597.09	55.79	56.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	644.67	57.98	53.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	464.00	60.84	54.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	748.14	78.75	72.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	697.32	93.09	81.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	497.74	65.21	46.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	610.11	86.01	61.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	590.74	74.63	61.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	498.16	26.59	24.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1236.23	84.58	58.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	639.05	44.68	38.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	639.79	36.67	37.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	621.36	51.75	41.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	591.10	38.43	41.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	782.86	46.54	60.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	405.33	36.43	35.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	735.99	81.90	68.16
immature langerhans cells, donor1	11904-125F5	268.78	50.37	28.57
immature langerhans cells, donor2	11905-125F6	266.95	41.98	43.57
insula, adult, pool1	10039-101F3	252.10	54.32	36.15
keratoacanthoma cell line:HKA-1	10791-110H8	553.40	97.54	64.38
kidney, adult, pool1	10017-101C8	304.49	56.27	41.75
kidney, fetal, pool1	10045-101F9	301.55	35.30	31.05
large cell lung carcinoma cell line:IA-LM	10509-107D5	461.43	65.61	51.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	360.53	39.68	32.90
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	531.23	45.87	41.10
left atrium, adult, donor1	10079-102A7	310.56	50.67	37.05
left ventricle, adult, donor1	10078-102A6	332.22	24.27	26.29
leiomyoblastoma cell line:G-402	10721-110A1	353.78	36.94	24.35
leiomyoma cell line:10964C	10569-108B2	451.94	49.22	40.60
leiomyoma cell line:15242A	10570-108B3	416.85	51.09	46.74
leiomyoma cell line:15425	10571-108B4	383.41	37.15	26.95
leiomyosarcoma cell line:Hs 5.T	10722-110A2	298.42	69.84	50.79
lens epithelial cell line:SRA 01/04	10647-109A8	414.04	42.87	50.19
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	587.46	87.48	62.92
liposarcoma cell line:KMLS-1	10782-110G8	350.38	42.49	34.52
liposarcoma cell line:SW 872	10726-110A6	383.67	54.34	47.76
liver, adult, pool1	10018-101C9	420.39	60.12	48.29
liver, fetal, pool1	10086-102B5	333.95	33.87	38.57
locus coeruleus - adult, donor10196	10182-103D2	397.81	61.98	50.75
locus coeruleus, adult, donor10252	10165-103B3	270.18	39.68	33.22
locus coeruleus, adult, donor10258	10375-105G6	229.66	48.25	42.60
locus coeruleus, newborn, donor10223	10362-105F2	287.28	34.49	38.28
lung adenocarcinoma cell line:A549	10499-107C4	309.31	41.38	35.15
lung adenocarcinoma cell line:PC-14	10408-106B3	235.78	18.61	24.82
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	216.18	22.28	16.74
lung, adult, pool1	10019-101D1	231.06	18.07	14.88
lung, fetal, donor1	10068-101I5	561.68	30.82	46.81
lung, right lower lobe, adult, donor1	10075-102A3	289.59	34.82	37.12
lymph node, adult, donor1	10077-102A5	310.53	36.45	26.51
lymphangiectasia cell line:DS-1	10727-110A7	455.67	78.03	35.07
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	278.31	40.75	27.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	485.06	39.93	36.53
mature adipocyte, donor1	12231-129F8	245.08	22.20	23.09
mature adipocyte, donor2	12232-129F9	217.90	23.45	19.51
mature adipocyte, donor3	12233-129G1	224.50	24.18	19.44
mature adipocyte, donor4	12234-129G2	321.65	38.96	29.48
maxillary sinus tumor cell line:HSQ-89	10414-106B9	359.53	45.51	41.22
medial frontal gyrus - adult, donor10196	10170-103B8	369.99	84.60	56.40
medial frontal gyrus, adult, donor10252	10150-102I6	310.43	61.06	41.38
medial frontal gyrus, adult, donor10258	10368-105F8	459.69	92.13	71.48
medial frontal gyrus, newborn, donor10223	10352-105E1	503.26	75.06	74.64
medial temporal gyrus - adult, donor10196	10183-103D3	546.42	103.11	76.95
medial temporal gyrus, adult, donor10252	10156-103A3	334.68	73.22	49.45
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	693.45	32.75	52.01
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	172.24	71.77	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	412.05	63.89	50.97
medulla oblongata - adult, donor10196	10174-103C3	333.57	44.78	51.92
medulla oblongata, adult, donor10252	10155-103A2	256.82	32.97	27.09
medulla oblongata, adult, pool1	10038-101F2	230.68	37.39	27.75
medulla oblongata, newborn, donor10223	10361-105F1	352.04	41.31	38.88
medulloblastoma cell line:D283 Med	10838-111E1	370.64	30.55	31.66
medulloblastoma cell line:ONS-76	10759-110E3	271.20	38.15	26.41
melanoma cell line:COLO 679	10514-107E1	198.80	35.79	27.31
melanoma cell line:G-361	10465-106H6	444.11	31.22	29.86
meningioma cell line:HKBMM	10691-109F7	348.78	23.34	27.86
merkel cell carcinoma cell line:MKL-1	10843-111E6	671.44	103.10	77.54
merkel cell carcinoma cell line:MS-1	10844-111E7	510.15	90.47	66.36
mesenchymal precursor cell - adipose, donor1	11747-123G1	329.88	36.82	31.30
mesenchymal precursor cell - adipose, donor2	11748-123G2	295.76	24.54	23.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	419.90	24.85	23.19
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	220.41	18.68	14.75
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	282.88	30.04	20.03
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	428.25	53.44	47.89
mesenchymal precursor cell - cardiac, donor1	11752-123G6	373.82	40.85	30.21
mesenchymal precursor cell - cardiac, donor2	11753-123G7	255.68	19.67	19.55
mesenchymal precursor cell - cardiac, donor3	11754-123G8	254.66	26.93	26.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	277.91	30.79	26.87
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	242.84	30.02	24.90
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	396.54	40.18	36.23
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	288.78	33.21	28.37
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	313.83	36.65	29.67
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	257.66	26.54	18.99
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	341.48	33.43	28.76
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	239.28	18.41	18.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	235.06	35.57	32.83
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	323.06	27.69	32.73
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	234.32	30.63	26.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	237.56	24.42	24.86
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	329.50	20.25	22.46
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	260.98	39.78	28.33
mesenchymal stem cell line:Hu5/E18	10568-108B1	468.17	58.52	45.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	386.80	41.10	32.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	346.08	28.14	27.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	359.39	31.15	25.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	324.11	31.12	28.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	332.56	27.07	21.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	372.30	31.48	31.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	366.64	22.40	30.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	374.88	25.02	24.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	579.64	96.61	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	388.21	33.17	27.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	319.70	29.45	25.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	328.80	29.80	24.76
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	345.40	31.53	21.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	347.74	26.52	22.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	379.08	33.57	22.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	345.79	38.23	22.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	516.80	32.81	38.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	413.20	36.15	36.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	405.98	28.58	36.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	407.40	27.64	42.19
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	541.61	41.58	36.25
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	445.69	32.71	31.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	512.33	33.43	31.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	426.04	29.38	25.18
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	446.07	29.80	26.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	381.38	42.90	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	425.75	39.14	29.65
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	378.94	31.68	28.02
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	378.73	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	531.41	34.84	29.14
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	424.23	30.70	30.35
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	356.77	40.83	32.24
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	455.06	19.96	35.93
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	444.26	27.55	24.11
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	483.26	29.75	27.30
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	463.16	27.01	27.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	476.34	24.17	23.58
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	527.40	33.04	22.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	475.86	32.08	24.06
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	527.47	29.57	21.29
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	536.71	46.22	33.38
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	437.13	28.91	21.34
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	430.98	25.73	24.25
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	430.66	31.40	23.55
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	421.71	26.08	33.71
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	562.97	46.34	39.49
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	527.70	43.61	43.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	506.82	51.95	38.01
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	376.27	33.38	33.99
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	546.80	49.71	40.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	452.20	38.71	46.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	302.20	17.66	16.67
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	460.13	31.15	25.96
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	394.21	28.52	18.34
mesodermal tumor cell line:HIRS-BM	10696-109G3	396.14	55.71	41.78
mesothelioma cell line:ACC-MESO-1	10493-107B7	416.26	11.81	13.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	330.13	21.08	27.80
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	405.99	38.46	59.83
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	642.50	77.06	59.90
mesothelioma cell line:Mero-25	10850-111F4	765.51	82.61	81.48
mesothelioma cell line:Mero-41	10851-111F5	377.23	24.45	28.36
mesothelioma cell line:Mero-48a	10852-111F6	396.58	54.03	35.21
mesothelioma cell line:Mero-82	10853-111F7	581.85	79.10	82.26
mesothelioma cell line:Mero-83	10854-111F8	379.42	53.79	45.96
mesothelioma cell line:Mero-84	10855-111F9	332.40	21.49	26.29
mesothelioma cell line:Mero-95	10856-111G1	288.00	44.31	38.72
mesothelioma cell line:NCI-H2052	10847-111F1	297.17	34.79	33.46
mesothelioma cell line:NCI-H226	10846-111E9	312.57	41.99	33.12
mesothelioma cell line:NCI-H2452	10848-111F2	333.27	42.19	43.05
mesothelioma cell line:NCI-H28	10845-111E8	483.23	65.14	59.80
mesothelioma cell line:No36	10857-111G2	312.18	23.49	24.14
mesothelioma cell line:ONE58	10858-111G3	689.30	58.80	61.78
migratory langerhans cells, donor1	11901-125F2	560.03	90.59	89.82
migratory langerhans cells, donor2	11902-125F3	487.12	57.64	71.68
migratory langerhans cells, donor3	11903-125F4	594.62	72.33	76.64
mixed mullerian tumor cell line:HTMMT	10689-109F5	586.36	23.51	35.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	322.99	80.11	57.86
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	721.71	89.38	65.65
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	292.67	51.19	41.10
myelodysplastic syndrome cell line:SKM-1	10772-110F7	402.29	44.35	40.65
myeloma cell line:PCM6	10474-106I6	569.68	86.38	86.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	447.43	94.86	74.06
myxofibrosarcoma cell line:NMFH-1	10684-109E9	300.68	21.77	23.93
nasal epithelial cells, donor1, tech_rep1	12226-129F3	320.35	10.81	12.93
nasal epithelial cells, donor1, tech_rep2	12226-129F3	358.29	13.31	11.77
nasal epithelial cells, donor2	12227-129F4	184.92	9.38	6.62
neuroblastoma cell line:CHP-134	10508-107D4	608.74	49.69	27.15
neuroblastoma cell line:NB-1	10539-107G8	350.22	48.64	35.36
neuroblastoma cell line:NBsusSR	10607-108F4	468.38	30.79	36.48
neuroblastoma cell line:NH-12	10555-107I6	1138.05	57.58	57.96
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	550.13	24.67	19.69
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	473.24	48.15	33.42
neuroectodermal tumor cell line:TASK1	10774-110F9	409.36	30.99	19.52
neuroepithelioma cell line:SK-N-MC	10728-110A8	549.30	31.15	27.97
neurofibroma cell line:Hs 53.T	10729-110A9	479.37	58.29	46.05
neutrophil PMN, donor1	12133-128D9	193.37	29.75	14.87
neutrophil PMN, donor2	12137-128E4	199.21	39.84	26.56
neutrophil PMN, donor3	12141-128E8	293.59	56.82	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	231.86	18.77	11.84
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	213.74	42.43	24.02
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	428.33	41.36	31.10
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	466.14	52.03	47.56
nucleus accumbens, adult, pool1	10037-101F1	230.60	47.34	30.56
occipital cortex - adult, donor10196	10172-103C1	395.59	76.23	45.33
occipital cortex, adult, donor10252	10163-103B1	332.50	50.72	38.91
occipital cortex, newborn, donor10223	10355-105E4	378.14	51.68	37.12
occipital lobe, adult, donor1	10076-102A4	291.79	67.17	48.54
occipital lobe, fetal, donor1	10073-102A1	554.83	26.60	23.17
occipital pole, adult, pool1	10036-101E9	210.35	49.67	31.93
olfactory region, adult	10195-103E6	310.65	59.23	50.25
optic nerve, donor1	10277-104E7	698.37	88.05	100.05
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	431.94	58.89	39.87
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	355.56	15.66	10.03
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	475.97	39.45	35.90
oral squamous cell carcinoma cell line:SAS	10544-107H4	381.18	45.16	31.30
osteoclastoma cell line:Hs 706.T	10704-109H2	343.94	40.86	37.33
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	369.06	34.57	22.42
osteosarcoma cell line:HS-Os-1	10558-107I9	175.58	18.45	16.96
ovary, adult, pool1	10020-101D2	318.83	15.55	12.23
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	260.86	27.31	24.56
pancreas, adult, donor1	10049-101G4	1291.50	147.68	138.27
pancreatic carcinoma cell line:NOR-P1	10698-109G5	591.22	64.57	61.22
papillary adenocarcinoma cell line:8505C	10437-106E5	652.45	72.06	59.28
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	326.03	45.70	29.14
paracentral gyrus, adult, pool1	10035-101E8	226.52	50.70	35.05
parietal cortex, adult, donor10258	10373-105G4	274.52	41.10	40.37
parietal lobe - adult, donor10196	10171-103B9	360.21	63.95	57.37
parietal lobe, adult, donor10252	10157-103A4	312.40	54.73	40.48
parietal lobe, adult, pool1	10034-101E7	217.74	56.93	31.37
parietal lobe, fetal, donor1	10072-101I9	876.73	45.58	54.31
parietal lobe, newborn, donor10223	10356-105E5	398.53	61.31	41.12
parotid gland, adult	10199-103F1	685.73	93.12	76.47
penis, adult	10200-103F2	327.64	31.69	39.75
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	491.24	17.66	15.06
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	449.32	68.33	49.24
pineal gland - adult, donor10196	10179-103C8	265.11	56.12	50.31
pineal gland, adult, donor10252	10160-103A7	242.21	49.75	49.15
pineal gland, adult, donor10258	10377-105G8	247.69	68.98	70.23
pituitary gland - adult, donor10196	10180-103C9	457.33	48.57	39.46
pituitary gland, adult, donor10252	10162-103A9	448.74	52.64	43.78
pituitary gland, adult, donor10258	10378-105G9	447.75	55.33	62.14
placenta, adult, pool1	10021-101D3	214.79	37.20	28.06
plasma cell leukemia cell line:ARH-77	10840-111E3	481.24	50.85	36.81
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	241.40	18.05	15.25
pons, adult, pool1	10033-101E6	179.45	40.02	27.80
postcentral gyrus, adult, pool1	10032-101E5	252.63	57.97	37.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	200.77	29.28	23.01
promyelocytes/myelocytes PMC, donor2	12136-128E3	501.23	38.56	88.13
promyelocytes/myelocytes PMC, donor3	12140-128E7	727.62	23.47	35.21
prostate cancer cell line:DU145	10490-107B4	334.29	25.78	21.27
prostate cancer cell line:PC-3	10439-106E7	381.70	36.48	32.31
prostate, adult, pool1	10022-101D4	280.96	18.05	20.95
putamen, adult, donor10196	10176-103C5	345.83	69.17	47.21
putamen, adult, donor10252	10152-102I8	386.26	43.14	41.18
putamen, adult, donor10258, tech_rep1	10372-105G3	475.37	41.53	36.06
putamen, adult, donor10258, tech_rep2	10372-105G3	273.02	50.74	43.25
putamen, newborn, donor10223	10365-105F5	284.12	28.49	20.99
rectal cancer cell line:TT1TKB	10469-106I1	231.29	25.02	19.49
rectum, fetal, donor1	10067-101I4	724.71	59.81	66.77
renal cell carcinoma cell line:OS-RC-2	10411-106B6	285.99	21.20	20.35
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	451.90	13.67	14.50
retina, adult, pool1	10030-101E3	243.43	35.88	30.02
retinoblastoma cell line:Y79	10475-106I7	459.85	54.30	36.37
rhabdomyosarcoma cell line:KYM-1	10787-110H4	288.68	28.65	28.28
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	242.96	17.43	14.90
sacrococcigeal teratoma cell line:HTST	10695-109G2	697.98	28.04	19.70
salivary acinar cells, donor1	11771-123I7	271.92	31.08	18.45
salivary acinar cells, donor2	11772-123I8	321.50	29.88	24.92
salivary acinar cells, donor3	11773-123I9	398.56	46.34	37.74
salivary gland, adult, pool1	10093-102C3	819.04	81.22	89.80
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	236.75	20.82	16.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	295.76	33.62	26.80
seminal vesicle, adult	10201-103F3	515.84	66.66	69.31
serous adenocarcinoma cell line:JHOS-2	10639-108I9	365.60	68.75	68.75
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	349.77	31.96	28.69
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	467.65	44.16	33.12
serous cystadenocarcinoma cell line:HTOA	10693-109F9	586.31	82.07	61.65
signet ring carcinoma cell line:Kato III	10436-106E4	640.29	96.05	65.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	525.52	79.74	56.38
skeletal muscle - soleus muscle, donor1	10282-104F3	893.05	95.76	95.76
skeletal muscle, adult, pool1	10023-101D5	377.80	50.37	49.53
skeletal muscle, fetal, donor1	10066-101I3	557.78	43.22	53.27
skin, adult, donor1	10074-102A2	332.48	13.57	33.93
skin, fetal, donor1	10065-101I2	422.92	35.35	27.77
small cell cervical cancer cell line:HCSC-1	10800-110I8	605.68	61.70	47.69
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	479.74	78.49	53.27
small cell lung carcinoma cell line:DMS 144	10841-111E4	282.57	13.88	13.30
small cell lung carcinoma cell line:LK-2	10541-107H1	453.93	44.17	22.91
small cell lung carcinoma cell line:NCI-H82	10842-111E5	393.76	12.22	7.40
small cell lung carcinoma cell line:WA-hT	10562-108A4	565.71	108.30	109.39
small intestine, adult, pool1	10024-101D6	566.88	128.28	96.51
small intestine, fetal, donor1	10064-101I1	653.31	104.18	81.82
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	579.58	72.83	46.67
smooth muscle, adult, pool1	10048-101G3	305.49	24.55	22.49
somatostatinoma cell line:QGP-1	10781-110G7	774.31	157.86	93.27
spinal cord - adult, donor10196	10181-103D1	508.36	76.62	61.25
spinal cord, adult, donor10252	10159-103A6	259.04	16.56	19.32
spinal cord, adult, donor10258	10369-105F9	435.14	43.58	58.80
spinal cord, fetal, donor1	10056-101H2	412.25	65.86	59.15
spinal cord, newborn, donor10223	10359-105E8	534.98	61.53	75.31
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	465.09	50.48	41.37
spleen, adult, pool1	10025-101D7	212.23	29.63	22.80
spleen, fetal, pool1	10044-101F8	205.55	23.92	19.94
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	210.96	39.85	25.46
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	573.81	46.71	37.98
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	392.78	71.29	59.41
squamous cell carcinoma cell line:T3M-5	10616-108G4	848.71	51.99	45.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	304.92	86.56	51.89
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	154.61	9.74	14.83
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	307.57	19.88	26.23
stomach, fetal, donor1	10062-101H8	772.14	98.25	70.49
submaxillary gland, adult	10202-103F4	556.01	89.44	63.80
substantia nigra - adult, donor10196	10178-103C7	651.29	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	279.36	25.34	28.66
substantia nigra, adult, donor10258	10371-105G2	375.52	38.28	61.55
substantia nigra, newborn, donor10223	10358-105E7	470.58	37.45	47.34
synovial sarcoma cell line:HS-SY-II	10441-106E9	215.74	24.53	23.16
temporal lobe, adult, pool1	10031-101E4	285.93	65.78	37.21
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	891.05	52.00	58.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	637.33	35.60	50.11
tenocyte, donor1	11763-123H8	482.46	32.82	27.58
tenocyte, donor2	11765-123I1	394.86	37.39	25.56
tenocyte, donor3	11768-123I4	400.69	29.28	30.77
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	420.82	52.52	40.11
teratocarcinoma cell line:NCR-G1	10798-110I6	415.28	58.11	36.53
teratocarcinoma cell line:PA-1	10807-111A6	358.93	42.46	19.22
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	269.64	50.14	34.53
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	603.18	45.38	42.73
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	265.24	31.85	23.23
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	509.72	37.46	51.79
testis, adult, pool1	10026-101D8	218.07	20.29	18.68
testis, adult, pool2	10096-102C6	427.18	37.89	49.62
thalamus - adult, donor10196	10168-103B6	426.14	48.58	52.99
thalamus, adult, donor10252	10154-103A1	312.25	32.98	32.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	725.16	38.49	35.41
thalamus, adult, donor10258, tech_rep2	10370-105G1	217.23	44.30	36.56
thalamus, newborn, donor10223	10366-105F6	360.73	69.61	39.70
throat, adult	10209-103G2	293.61	38.70	37.70
throat, fetal, donor1	10061-101H7	448.83	73.43	67.64
thymic carcinoma cell line:Ty-82	10803-111A2	357.72	32.59	29.21
thymus, adult, pool1	10027-101D9	249.83	24.95	21.67
thymus, fetal, pool1	10043-101F7	202.41	20.88	17.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	346.89	35.77	32.58
thyroid carcinoma cell line:TCO-1	10783-110G9	536.97	47.91	39.67
thyroid, adult, pool1	10028-101E1	345.82	41.34	45.44
thyroid, fetal, donor1	10060-101H6	518.62	105.20	102.56
tongue epidermis (fungiform papillae), donor1	10288-104F9	609.76	89.31	58.51
tongue, adult	10203-103F5	333.52	46.05	39.31
tongue, fetal, donor1	10059-101H5	494.98	75.67	73.70
tonsil, adult, pool1	10047-101G2	312.95	44.68	29.35
trachea, adult, pool1	10029-101E2	262.57	30.27	23.97
trachea, fetal, donor1	10058-101H4	436.63	44.24	33.47
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	449.93	66.25	34.01
transitional-cell carcinoma cell line:5637	10418-106C4	369.10	44.58	36.88
transitional-cell carcinoma cell line:JMSU1	10492-107B6	404.72	40.11	34.94
tridermal teratoma cell line:HGRT	10694-109G1	700.13	45.66	41.86
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	459.06	52.99	39.62
umbilical cord, fetal, donor1	10057-101H3	319.23	31.30	16.69
uterus, adult, pool1	10100-102D1	398.42	21.16	27.64
uterus, fetal, donor1	10055-101H1	474.05	30.20	29.18
vagina, adult	10204-103F6	294.02	9.69	17.45
vein, adult	10191-103E2	364.31	43.84	39.67
xeroderma pigentosum b cell line:XPL 17	10563-108A5	414.17	38.45	28.31